Novel Systemic Treatment Modalities Including Immunotherapy and Molecular Targeted Therapy for Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma

Head and neck squamous cell carcinomas (HNSCCs) are the sixth most common cancers worldwide. More than half of patients with HNSCC eventually experience disease recurrence and/or metastasis, which can threaten their long-term survival. HNSCCs located in the oral cavity and larynx are usually associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Soma, Shah, Pooja A., Johnson, Faye M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320653/
https://www.ncbi.nlm.nih.gov/pubmed/35887235
http://dx.doi.org/10.3390/ijms23147889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320653/
https://www.ncbi.nlm.nih.gov/pubmed/35887235
http://dx.doi.org/10.3390/ijms23147889

Ejemplares similares